Literature DB >> 14614329

Differentially expressed apoptotic genes in early stage lung adenocarcinoma predicted by expression profiling.

Sunil Singhal1, Kunjlata M Amin, Robert Kruklitis, M Blair Marshall, John C Kucharczuk, Peter DeLong, Leslie A Litzky, Larry R Kaiser, Steven M Albelda.   

Abstract

OBJECTIVE: In undiseased lung epithelial cells, apoptosis is an evolutionarily conserved and genetically regulated form of cell suicide which plays an important role in development and in the maintenance of tissue homeostasis. Neoplastic lung cells develop the ability to deregulate growth by alterations in these genes which control apoptosis. Genomic profiling was used to compare gene expression levels in early stage lung adenocarcinomas and nonneoplastic pulmonary tissue in order to comprehensively identify alterations in the process of apoptosis.
METHODS: RNA extracted from node negative, poorly differentiated lung adenocarcinomas (15 patients) and nonneoplastic pulmonary tissue (5 patients) was hybridized to oligonucleotide microarray filters containing 44,363 genes. Ontological classification was used to extract genes involved with apoptosis. Further analysis discovered a subset of differentially expressed genes for further study.
RESULTS: Of the 308 apoptotic genes on the microarray filters, 24 genes were predicted to be differentially expressed in lung adenocarcinomas. Alterations in several genes (i.e., Akt, BcL-xL, PTEN, FAS) are consistent with the literature. We also identified 10 novel genes that have not been described in nonsmall cell lung cancer (i.e., RIP, Caspase 1, PDK-1).
CONCLUSIONS: These results identified several potential apoptotic genes altered in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614329     DOI: 10.4161/cbt.2.5.514

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  4 in total

Review 1.  Targeting the Mammalian Target of Rapamycin in Lung Cancer.

Authors:  Glenn W Vicary; Jesse Roman
Journal:  Am J Med Sci       Date:  2016-08-21       Impact factor: 2.378

2.  Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.

Authors:  M C Boelens; A van den Berg; I Vogelzang; J Wesseling; D S Postma; W Timens; H J M Groen
Journal:  J Clin Pathol       Date:  2006-02-17       Impact factor: 3.411

Review 3.  Gene expression profiling of non-small cell lung cancer.

Authors:  Sunil Singhal; Daniel Miller; Suresh Ramalingam; Shi-Yong Sun
Journal:  Lung Cancer       Date:  2008-04-25       Impact factor: 5.705

4.  Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.

Authors:  Bodo Schniewind; Kirsten Heintz; Roland Kurdow; Ole Ammerpohl; Anna Trauzold; Doris Emme; Peter Dohrmann; Holger Kalthoff
Journal:  J Carcinog       Date:  2006-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.